Join our Community
Support ToI and remove all ads
Learn more
search
MARILYNN MARCHIONE
US President Donald Trump walks out of Walter Reed National Military Medical Center to return to the White House after receiving treatments for covid-19, Monday, Oct. 5, 2020, in Bethesda, Md. (AP Photo/Evan Vucci)
October 8, 2020, 3:02 am
Ethicists say Trump special treatment raises fairness issues
US resident given rare access to experimental drug; questions also raised as to quality of treatment, with many details on his condition withheld from public
By MARILYNN MARCHIONE
In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. (Regeneron via AP)
October 3, 2020, 3:51 am
Trump gets experimental drug aimed at curbing severe illness
Antibody cocktail is in late-stage testing and its safety and effectiveness are not yet known, but maker Regeneron says it might reduce the period symptoms last
By MARILYNN MARCHIONE
In this September 29, 2020, file photo, US President Donald Trump holds out his face mask during the first presidential debate at Case Western University and Cleveland Clinic, in Cleveland, Ohio. (AP/Julio Cortez, File)
October 2, 2020, 9:19 pm
Trump’s age, health woes raise his risk level in COVID-19 illness
At 74, president’s age would be the primary risk factor, says infectious disease expert; Trump’s also obese, with a BMI over 30, which lowers immunity to virus
By MARILYNN MARCHIONE
A lab technician prepares chemicals to process COVID-19 tests in Argenteuil, near Paris, Sept. 25, 2020. (AP Photo/Francois Mori)
September 27, 2020, 8:18 pm
Million who died of COVID-19 also illuminated treatment
Many more deaths expected as infections surge in US and elsewhere, but there are signs death rate is declining, partially due to hard-fought medical advances
By MARILYNN MARCHIONE
Illustrative: A COVID-19 patient lies face down as a nurse prepares an injection in the ICU of the National Hospital in Itagua, Paraguay, September 7, 2020. (AP Photo/Jorge Saenz)
September 16, 2020, 6:43 pm
Study suggests antibody drug may cut COVID-19 hospitalizations
While tests of drug fell short of main goals, Eli Lilly says results hinting fewer people with virus may need to be hospitalized are an encouraging ‘proof of principle’
By MARILYNN MARCHIONE
In this image from video provided by Washington University, researcher Nicolas Barthelemy works on a p-tau217 test for Alzheimer's disease at a laboratory in St. Louis, Missouri on July 27, 2020. (Huy Mach/Washington University, St. Louis via AP)
July 30, 2020, 9:09 am
Scientists get closer to blood test for Alzheimer’s disease
Testing identifies people with disease with accuracy ranging from 89% to 98%, but scientists warn new approach still needs more validation
By MARILYNN MARCHIONE
A health worker draws blood from a patient for a COVID-19 antibody test at the Volusia County Fairgrounds in DeLand, Florida, on May 5, 2020. (AP Photo/John Raoux)
July 23, 2020, 5:42 am
Coronavirus antibodies fade fast, but protection may last longer
Initial research shows blood cells remember how to efficiently make new antibodies in case of reinfection, meaning someone can have immunity even without antibodies
By MARILYNN MARCHIONE
In this photo taken on May 2, 2020, doctors work inside the intensive care unit for people infected with the new coronavirus, at a hospital in Moscow, Russia. (AP Photo/Sophia Sandurskaya)
July 8, 2020, 10:18 am
‘Desperation science’ slows the hunt for coronavirus medicine
Ironically, attempts to fast-track research on COVID-19 drugs have led to a slew of low-quality studies that add to confusion. And statements by politicians aren’t helping either
By MARILYNN MARCHIONE
George Floyd. (Christopher Harris via AP)
June 5, 2020, 6:42 am
Experts say Floyd’s health issues don’t affect homicide ruling
Autopsy report on George Floyd finds severe heart disease, drugs in system, which would have made reaction to stress more severe, but not caused death, medical reviewers say
By MARILYNN MARCHIONE
A bottle of hydroxychloroquine tablets in Texas City, Texas, April 7, 2020. (AP Photo/David J. Phillip, File)
June 5, 2020, 12:13 am
Study raising concerns about using hydroxychloroquine to treat virus retracted
Several authors of research in Lancet say they ‘can no longer vouch for the veracity of the primary data sources’ after independent reviewers unable to verify information
By MARILYNN MARCHIONE
Rubber stoppers are placed onto filled vials of the remdesivir at a Gilead manufacturing site in the US, in March 2020. (Gilead Sciences via AP)
May 2, 2020, 12:58 am
Trump announces emergency approval for 1st drug shown to help virus recovery
In preliminary US trial, Gilead Science’s remdesivir shortens recovery time by 4 days; cleared for use for hospitalized patients with ‘severe disease’
By MATTHEW PERRONE and MARILYNN MARCHIONE
A vial of Gilead Sciences' remdesivir drug is seen during a press conference about the start of a study with drug in particularly ill coronavirus patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020. (Ulrich Perrey/Pool/AFP)
April 29, 2020, 7:35 pm
Experimental drug declared by US as first effective treatment against COVID-19
Dr. Anthony Fauci says trial on patients shows GIlead Sciences remdesivir ‘can block this virus,’ American government to work to boost availability of the antiviral medication
By Martin Crutsinger, MARILYNN MARCHIONE and Anne D'Innocenzio
In this April 10, 2020, file photo, amid coronavirus concerns, a US healthcare worker takes the temperature of a visitor to Essentia Health who was crossing over a skywalk bridge from the adjoining parking deck, in Duluth, Minnesota. (Alex Kormann/Star Tribune via AP, File)
April 20, 2020, 9:32 am
Uncertainty around asymptomatic virus cases sparks hopes and fears
Much research, better testing required to know extent of under-the-radar cases; it means more people around us may be infected, but shortens path to supposed herd immunity
By MARILYNN MARCHIONE
In this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in Philadelphia. (Penn Medicine via AP)
November 6, 2019, 6:36 pm
In first, US doctors try CRISPR gene editing for cancer treatment
Procedure that bolsters patients’ immune systems by helping cells better identify and fight against cancer has so far yielded encouraging results
By MARILYNN MARCHIONE
In this December 15, 2018 photo, Supreme Court Justice Ruth Bader Ginsburg appears at an event organized by the Museum of the City of New York with WNET-TV held at the New York Academy of Medicine in New York. (AP Photo/Rebecca Gibian)
August 23, 2019, 9:59 pm
Supreme Court: Ruth Bader Ginsburg treated for tumor on pancreas
Officials say judge completed radiation therapy, no evidence of disease remaining in her 4th bout with cancer since she joined the court in 1993
By Jessica Gresko and MARILYNN MARCHIONE
Load More
Is our work important
to you?

Does The Times of Israel give you valuable insight into Israel and the Jewish world?
If so, please join The Times of Israel Community.
For as little as $6/month, you will:

  • Support our independent journalism;
  • Enjoy an ad-free experience on the ToI site, apps and emails; and
  • Unlock exclusive content shared only with the ToI Community, like our new Behind the Headlines interview series with thought leaders, and weekly letters from founding editor David Horovitz.
Join the times of israel community Join our community Already a member? Sign in to stop seeing this